Biogen | BIIB - 股票

金融业

USD

USD 29.48B

现金及等价物

USD 3.38B

USD 797.5M

USD 9.19B

USD 3B

USD 6.56B

USD 514.3M

USD 649.7M

7.61K

EPS每股收益

USD 3.57

股本和储备

USD 18.65B

USD 1.82B

债务利息支出

USD 72.6M

USD 37.9M

USD 6.29B

USD 29.42B

USD 319.5M

USD 1.96B

USD 514.3M

普通股股本

USD 146.7M

13.7

USD 377.7M

USD 2.25B

销售和管理费用

USD 554.3M

USD 1.95B

贸易债权人

USD 358.5M

应收帐款人

USD 1.79B

	股票	更改		日
AbbVie	USD 5.05B		98M	2026-03
Acadia Pharmaceuticals	USD 31.57M		3.1M	2026-03
ALKERMES	USD 298.96M		37.75M	2026-06
Amgen	USD 6.19B		39M	2026-03
Bayer	EUR 12.34B		3M	2025-12
Biogen	USD 1.95B		219.1M	2026-03
BioMarin Pharmaceutical	USD 1.27B		25.66M	2026-03
Bristol-Myers Squibb	USD 2.76B		66M	2026-03
Eli Lilly	USD 14.53B		785M	2026-03
Gilead Sciences	USD 1.91B		140M	2026-03
Incyte	USD 115.62M		14.56M	2026-03
Merck	USD 6.48B		179M	2026-03
Moderna	USD 146M		7M	2026-03
Neurocrine Biosciences	USD 64.5M		4.5M	2026-03
Novartis	USD 6.22B		66M	2026-06
Pfizer	USD 10.67B		13M	2026-03
PTC Therapeutics	USD 75.57M		4.08M	2026-03
Puma Biotechnology	USD 9.48M		885K	2025-09
Regeneron Pharmaceuticals	USD 3.1B		97.2M	2026-03
Sanofi	EUR 22.69B		1.81B	2025-12
Sanofi	EUR 23.5B		812M	2026-03
Sarepta Therapeutics	USD 1B		86.37M	2026-03
Teva Pharmaceutical Industries	USD 3.18B		144M	2025-12
Ultragenyx Pharmaceutical	USD 55M		3M	2026-03
United Therapeutics	USD 178.3M		4.8M	2026-03
Vertex Pharmaceuticals	USD 1.77B		79.9M	2026-03